Ep125: Barry Greene on a New Drug for Depression
Podcast: The Long Run with Luke TimmermanPublished On: Mon Dec 19 2022
Description: Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
The note was deleted
The note was saved
Your message was sent